PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Vantive Us Hlthcare	PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER	calcium chloride; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	INJECTABLE;INJECTION	207026	NDA	Vantive US Healthcare LLC	24571-116-06	2 BAG in 1 CASE (24571-116-06) / 5 L in 1 BAG	2015-01-13
Vantive Us Hlthcare	PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER	calcium chloride; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	INJECTABLE;INJECTION	207026	NDA	Vantive US Healthcare LLC	24571-117-06	2 BAG in 1 CASE (24571-117-06) / 5 L in 1 BAG	2015-01-13
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: May 15, 2026

What suppliers make PHOXILLUM BK 4/2.5 IN plastic container (Phoxillum) and where does procurement risk sit?

Executive summary: PHOXILLUM BK 4/2.5 IN is a branded Baxter dialysis concentrate line. The plastic-container supply chain is dominated by Baxter’s licensed manufacturing network for PHOXILLUM bags/containers, with downstream procurement typically handled through national Baxter distributors/wholesalers. Procurement risk is primarily tied to (1) single-brand sourcing for a hospital product, (2) container/bag manufacturing and sterile-pack logistics, and (3) country-specific tendering and distributor coverage.

Scope note: “PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER” is a product-format search term. Without the country/market and package strength details that map to the local trade name, supplier lists can vary by distributor, tender, and regulatory market.

Who are the approved suppliers for PHOXILLUM BK 4/2.5 IN in plastic containers?

Featured snippet: In practice, approved “suppliers” for hospital use are the marketing authorization holder’s distribution network (typically Baxter distributors/wholesalers) and the underlying contract manufacturing sites that produce the plastic-bag/solution system.

Marketing authorization holder and distribution model

PHOXILLUM/PHOXILLUM BK products are marketed by Baxter in dialysis settings (commonly referenced as “Baxter” distribution in hospital procurement catalogs and tenders).
Distribution is usually executed through:
- Baxter direct sales to hospitals or group purchasing organizations
- Baxter-branded or Baxter-affiliated wholesalers
- Regional logistics partners that handle cold-chain or controlled-conditions shipment where applicable

Underlying manufacturing

The plastic container/bag and solution concentrate are produced by Baxter or Baxter’s qualified manufacturing partners.
Supplier qualification for hospitals often runs through:
- Regulatory compliance checks for local authorization
- Traceability for batch release
- Stability and packaging integrity validation for the plastic container format

Which companies provide PHOXILLUM BK 4/2.5 IN as a hospital procurement source?

Featured snippet: Procurement sources are typically Baxter’s appointed distributors plus national pharmaceutical wholesalers carrying Baxter hospital dialysis consumables.

Common procurement channels (typical pattern for dialysis concentrates)

Hospital group purchasing contracts listing Baxter as the primary brand
National wholesalers listing Baxter-manufactured products for ER and dialysis centers
Government or GPO tender awards naming Baxter supply routes

Substitutions and interchangeability

PHOXILLUM BK 4/2.5 IN is specific to dialysis chemistry and container presentation, so substitution is usually limited to:
- Same active electrolyte formulation and same container system class
- Same specification for dialysis concentrate composition and volume format
In practice, if a hospital switches brand, it is handled as a new clinical and procurement qualification cycle, not a simple SKU swap.

Does the plastic container format change who the suppliers are for PHOXILLUM BK 4/2.5 IN?

Featured snippet: Yes. Container-film, bag construction, and batch filling are part of the constrained supply chain, so the supplier for “the bag system” can be different from the supplier for “the bulk concentrate.”

Where container supply chain bottlenecks occur

Bag-film and welding/seal process quality
Sterility assurance and particulate control
Batch-level packaging integrity testing
Logistic packaging that protects the plastic container from puncture or deformation

Supplier mapping in diligence

When procurement teams evaluate continuity, they typically decompose sourcing into:

Electrolyte concentrate manufacturing
Plastic container/bag system sourcing
Filling and final packaging site
Distribution and warehousing

What suppliers exist in the PHOXILLUM BK 4/2.5 IN value chain (manufacturer vs distributor vs logistics)?

Featured snippet: The value chain splits into: maker of the dialysis concentrate, maker of the plastic bag/container system, and distributor/logistics provider for hospital delivery.

Value chain roles

Manufacturing site (concentrate + fill/finish)
Usually Baxter or a Baxter-qualified contract manufacturer.
Plastic container/bag system vendor (materials and build)
Often a specialized materials and packaging supplier under qualification.
Batch release and quality control
Run under GMP/QMS responsibility of the product authorization holder.
Wholesaler/distributor
Supplies hospitals via national distribution networks.
Logistics provider
Handles warehousing and last-mile distribution.

How do you identify the exact PHOXILLUM BK 4/2.5 IN suppliers from regulatory and label trace data?

Featured snippet: The most reliable mapping comes from package labeling, distribution records, and the local regulatory product file that lists the marketing authorization holder and manufacturing sites.

Practical identification points

Carton and bag label: manufacturer name, batch/lot number, manufacturing site address
Local regulatory listing: marketing authorization holder and manufacturing location(s)
Batch records (for major hospital accounts): fill site and release site
Distributor invoice records: named supplier entity for procurement accounting

Are there alternative suppliers or generics for PHOXILLUM BK 4/2.5 IN that compete on supply?

Featured snippet: For hospital dialysis concentrate products in most markets, branded supply dominates. Alternatives typically enter as:

Same-compound generic electrolyte concentrates
Repackaged or clinically equivalent concentrates under different brand names

Supply competition is constrained by

Stability, packaging validation, and container format qualification
Dialysis workflow integration at hospital centers
Tender specifications that lock to brand or exact composition and container presentation

What generic entry risks exist for PHOXILLUM BK 4/2.5 IN that could widen supplier availability?

Featured snippet: The main entry risk comes from replacement product qualification rather than rapid OTC-type generic launches. Hospitals require proof of equivalence under local procurement rules.

Risk drivers

Limited shelf-life or container-specific stability rules
Tender designs that specify formulation and container
Clinical protocol validation for dialysis centers

Key Takeaways

PHOXILLUM BK 4/2.5 IN plastic-container supply is driven by Baxter through its marketing authorization holder and distribution network.
The practical “supplier set” for procurement usually comprises Baxter distributors/wholesalers plus the qualified manufacturing sites that produce the concentrate and bag/fill system.
Container format introduces additional sourcing constraints at the plastic bag system and fill-finish levels.
Supplier substitution (brand switching) for dialysis concentrates depends on equivalence qualification and tender specification, so supplier diversity may be limited by procurement rules rather than pure commercial availability.

FAQs

1) Who supplies PHOXILLUM BK 4/2.5 IN to hospitals?
Typically Baxter through appointed national distributors/wholesalers, with manufacturers producing the filled plastic bag system under Baxter’s authorization.

2) Can I source PHOXILLUM BK 4/2.5 IN from alternative distributors?
Hospital supply usually works through Baxter’s contracted distributor network; other sellers may exist but will still route through approved supply channels for the local market.

3) Does the plastic container supplier matter for procurement continuity?
Yes. Container-film and bag build capacity can be a bottleneck that affects fill schedules and lead times.

4) Are there equivalent non-Baxter concentrates for the same dialysis chemistry?
In some markets, equivalents can exist under different brands, but tender specifications and container/formulation matching usually control interchangeability.

5) How do I confirm the exact manufacturing supplier on a shipment?
Use carton/bag labeling batch identifiers and the manufacturing site listed on the package and corresponding local regulatory entry for the product.

References

No sources were provided in the prompt to support a named list of specific supplier entities (manufacturers/distributors) for “PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER” by geography, so no citations can be responsibly enumerated.

Suppliers and packagers for PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER